HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
PDF Library
RSS Feeds
Subscribe
Advertising
Partnered Content
Report Store
UsernamePublicRestriction
Tags:
Innovation Business Strategies OTC Drugs

Bayer Harnessing Skin Microbiome In New Product Development

  • News

Executive Summary

Bayer has teamed up with skin microbiome specialist Azitra to develop consumer health products for a host of conditions. 

You may also be interested in...



Dutch Biotech Touts Enzyme-Powered Eczema Cream As ‘Smarter And Safer’ Solution

Headquartered in The Hague, Netherlands, Micreos is focused on developing targeted antibacterial products to replace antibiotics, protect against food contamination and treat inflammatory skin conditions. The firm’s Gladskin Eczema Cream, now available stateside, uses a patented enzyme technology to destroy Staphylococcus aureus bacteria while leaving skin’s beneficial flora intact.  

Nestlé Developing Microbiome-Based Supplements with Dutch Partner

Nestlé Health Science is putting its financial weight behind the Netherlands' Caelus Health to help commercialize microbiome-based food supplements for early intervention in a number of diseases.

DuPont Venture With Microbiome Startup Analyzing Probiotic Impact On Gut Health

DuPont Microbiome Venture signs agreement with BioMe Oxford to develop BioCapture ingestible capsule that samples gut health to assess the impact of probiotics and other nutrients on microbiome. Product should help shape future of precision medicine, firms say.

Table

View full table

Related Content

HBW Insight HBW Insight HBW Insight

Topics

Related Companies

Tags:
Innovation Business Strategies OTC Drugs
UsernamePublicRestriction

Register

RS149596

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By